mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |